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Senescence is a universal but poorly understood phenomenon among metaxoans. One 
theoretically convincing but unproven evolutionary theory of senescence is the pleiotropic 
gene theory of Williams (1957). This paper develops the hypothesis that some human 
genetic diseases exemplify the type of phenotypic effects predicted by this theory. The 
evidence supporting this contention is reviewed and ways of testing this hypothesis are 
suggested. Other human genetic diseases could be examined in the same manner. Con- 
firmation of this theory would have significant implications for the study of aging. 




enescence may be defined as the postmaturity decline in survivor- 
ship and fecundity that accompanies advancing age (Rose et al. 
1980). This phenomenon is an intrinsic property of metazoans and 
not the result of environmental hazard. Even in relatively optimal 
environments, all known animal species age and eventually die. 
As pointed out by Williams (1957)) senescence presents an apparent par- 
adox. All adult metazoans are the result of a complex process of development 
and morphogenesis. It seems surprising that after attaining maturity, animals 
are unable to perform the apparently simpler task of maintaining somatic 
integrity. Natural selection would also seem to militate against senescence. 
The direct effect of natural selection would tend to favor individuals able to 
maintain their somatic vigor and reproductive potential the longest. Yet, 
most metazoans are relatively short-lived, 
imals have ever been identified. 
Several theories have been proposed 
and no potentially immortal an- 
to account for the existence of 
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senescence (for review, see Kirkwood 1985). Some theories sidestep this 
issue, presuppose that senescence is a fundamental feature of metazoans, and 
focus on defining variables that might account for the differences in life span 
among metazoans. Other theories appeal to the idea of group selection, and 
most focus on proximate mechanisms of senescence. 
Probably the most rigorously developed theory of senescence is the pleio- 
tropic gene theory. First proposed by Williams in 1957 (Williams 1957), it 
has been independently formulated by Wallace (1967) and extended by Ham- 
ilton (1966). While the theory theoretically satisfying, it has proved difficult 
to accumulate evidence for or against this theory. This paper develops the 
hypothesis that certain human genetic diseases exemplify the phenotypic 
effects predicted by the pleiotropic gene theory. Some aspects of this hy- 
pothesis have been independently put forward by Wallace (1971) and Wallace 
and Parker (1973), though they have not received much attention. 
THE PLEIOTROPIC GENE THEORY 
The pleiotropic gene theory rests on three assumptions. The first is that a 
given phenotypic effect of a gene may be restricted to a portion or portions 
of an organism’s life history. The second assumption is that the impact on 
biologic fitness of any given gene is a function of the period(s) of the or- 
ganism’s life history during which the phenotypic effects are manifested. In 
general, the later in adult life a gene manifests itself, the less selective pres- 
sure it is exposed to. This occurs because the probability of individual sur- 
vival falls with advancing age. This is true even in a population of potentially 
immortal individuals because environmental hazards will operate to remove 
individuals from the population. Consequently, a gene whose effects are felt 
relatively late in adult life is less likely to be exposed to selective pressures 
than one whose effects are felt at an earlier age simply because fewer in- 
dividuals will survive to the age where the later onset gene has its effects. 
The third assumption is that a gene may be pleiotropic with respect to life 
history. That is, it may have one phenotypic effect during one portion of 
the life history and a different phenotypic during another portion of the life 
history. 
Williams suggested that pleiotropic genes producing a deleterious effect 
at some age could be the beneficiary of favorable overall selection pressure 
if they also produced a different and positive effect on biologic fitness at an 
earlier age. The relative value of the beneficial effect will be amplified and 
the deleterious effect diminished by virtue of their relative positioning in the 
life history of the organism. When such a mutation occurs in a population 
of potentially immortal individuals, the pleiotropic allele will drive competing 
alleles to extinction. Once established, the pleiotropic senescence gene 
would reinforce the value of new mutations conferring relatively early benefit 
and thus make it likely that other senescence genes of this type would spread 
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throughout the population. Hamilton (1966) has constructed models of this 
process and demonstrated that it could occur in primitive multicellular or- 
ganisms. In the long history of life, such genes could have arisen on many 
occasions, and metazoans are likely to possess many loci producing dele- 
terious late-life effects that originally conferred a selective advantage at ear- 
lier portions of the life span. 
Unfortunately, obtaining direct confirmation of this theory has proven 
difficult. Senescence is rarely observed in wild animal populations, and ob- 
taining the appropriate combination of demographic and genetic data in a 
wild population poses considerable difficulties. A recent study by Nesse 
(1988) of life table data for a wide variety of species showed that several 
species had a postmaturity acceleration of mortality rates, a finding predicted 
by the pleiotropic theory. Laboratory experiments using artiticial selection 
in flour beetles (Sokal 1970; Mertz 1975) and drosophila (Rose and Charles- 
worth 1980; Luckinbill et al. 1984; Rose and Charlesworth 1981a,b) have 
also tended to support the theory but conflicting results exist (Lints 1985). 
These discrepancies are probably resolvable on the basis of differences in 
experimental technique, and the preponderence of the evidence favors the 
pleiotropic gene theory (Luckinbill and Clare 1985; Clare and Luckinbill 
1985; Rose 1984). The supporting evidence consists of studies of genetic 
factors influencing longevity in selected strains of experimental animals. As 
yet, no one has isolated a specific allele or locus that satisfies the criteria 
of a pleiotropic senescence gene. 
Humans would appear to be good subjects for the evaluation of the 
pleiotropic gene theory. Senescence is easily observable in humans, and a 
good deal is known about human genetics and demography. If the theory is 
correct, it should be possible to derive predictions from the theory that 
accord with some of the known features of human aging. Further, it may be 
possible to identify specific genes within human populations that cause mor- 
bidity and mortality while conferring a selective benefit at an earlier age. 
Pleiotropic Gene Theory Predictions, Human Aging, and 
Human Genetic Disease 
Several predictions follow from this theory that are relevant to human aging 
(Alexander 1982, 1987): (1) Maximum life span should remain limited despite 
optimization of the environment because life span will ultimately be limited 
by senescence genes. Despite the advent of modern medicine and public 
health measures, maximum human life span seems not to have increased 
over the period of time for which adequate documents exist (Fries 1980). 
(2) Among species, adult death rates from environmental hazard should be 
inversely correlated with maximum longevity because in species exposed 
to relatively hazardous environments, the selective pressures favoring genes 
with relatively early benefit will be marked. Humans, as compared with other 
species, face a relatively lower degree of environmental hazard and are 
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among the most long lived of animals. (3) Where a sex difference exists, the 
sex that is exposed to a greater degree of environmental hazard should be 
more prone to senescence. In humans, adult males have a higher death rate 
from environmental hazard (especially intraspecies violence) and seem to 
be more prone to diseases of aging, especially atherosclerosis. (4) Senesc- 
ence should result from the action of multiple genes and produce the dys- 
function of multiple-cell types and organ systems because species are likely 
to accumulate multiple senescence genes over time. In the case of humans, 
this would correlate with the tendency of the aged to suffer from multiple 
chronic diseases and the gradual loss of functional reserve that occurs in all 
organ systems with human aging (Fries 1980). 
Human genetic diseases provide the opportunity to search for specific 
alleles that might satisfy the definition of a pleiotropic senescence gene. 
Several human genetic diseases have their onset relatively late in adulthood 
and thus serve as experiments of nature with which to examine the pleio- 
tropic gene theory. The identification of even one such allele as a pleiotropic 
senescence gene would provide strong supportive evidence for this theory 
of senescence. In addition, as the theory predicts that senescence genes are 
likely to be multiple and to affect multiple organ systems, we should be able 
to identify several different genetic diseases with different mechanisms of 
action that satisfy the definition of a pleiotropic senescence gene. A review 
of known adult onset human genetic diseases reveals three disorders that 
are good candidates for the role of pleiotropic senescence genes. As none 
of these disorders have been studied with the pleiotropic gene theory in 
mind, there is insufficient evidence to definitely identify any of them as 
pleiotropic senescence genes. Nonetheless, the evidence is suggestive and 
does identify these three diseases as promising candidates for evaluation of 
the pleiotropic gene theory. 
Huntington’s Disease 
Huntington’s disease (HD) is an autosomal dominant inherited neurodege- 
nerative disorder characterized by progressive impairment of voluntary 
movement and increasing involuntary movements, cognitive decline, and 
personality disturbance (Martin et al. 1986). Prevalence in the United States 
is estimated at 30-45 per million (Conneally 1984). Age of onset is typically 
in the latter part of the third decade and early part of the fourth decade of 
life. Death usually follows 15-20 years after onset and is attendent upon the 
relentless course of the cognitive and motor impairments. Molecular genetic 
analysis of patients from widely dispersed pedigrees around the world has 
shown that this phenotype is invariably associated with a single gene located 
on chromosome number 4. 
Virtually all clinicians who work with HD patients have been impressed 
by the size of sibships in afflicted families. This has given rise to speculation 
that HD victims are more fecund and consequently possess greater biologic 
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fitness than normals. Comparison of the fertility of HD victims with their 
unaffected siblings has revealed that in most surveyed areas HD victims 
produce more progeny than their unaffected sibs (Hayden 1981). The obvious 
objection is that this could result from diminished fertility of unaffected sibs 
rather than increased fertility of HD victims. Conflicting data exist on this 
point. Reed and Neel (1959) in their survey of HD in the state of Michigan 
(USA) and Shokeir (1975) in his survey of the provinces of Manitoba and 
Sasketchewan (Canada) have reported a depression of unaffected sib fertility 
as compared with the general population. On the other hand, Marx (1973), 
in her study of Minnesota (USA), and Stevens (1975) in the United Kingdom 
were unable to detect any differences between the fertility of unaffected sibs 
and the general population. 
Five studies have attempted to compare the fertility of HD victims with 
that of the general population. One study revealed lower than average fer- 
tility (Reed et al. 1959), one showed essentially the same fertility as the 
general population (Wallace and Parker 1973), and three others (Marx 1973; 
Shokeir 1975; Stevens 1975) claimed increased fertility as compared with 
the general population. The mean of all studies shows a reproductive ad- 
vantage of 1.09 over the general population. In the one study that revealed 
a diminished fertility relative to the general population, the authors con- 
cluded that diminished fertility was due in part to the premature termination 
of reproduction by institutionalization in mental hospitals. When the authors 
took this factor into account, relative fertility rose from 0.82 to 0.92 (the 
above calculation of mean reproductive advantage used the lower figure). 
This is of relevance because this study was conducted in the 1950s when 
institutionalization for psychiatric conditions was much more prevalent than 
it is today. Consequently, these fertility figures may be somewhat depressed 
because of a greater tendency to institutionalize patients with mild to mod- 
erate HD, a practice largely restricted to a few decades of modem history. 
In this study, case ascertainment was carried out to a large extent by review 
of the records of state-operated mental hospitals (Reed et al. 1958). At least 
one of the studies that found a reproductive advantage was based on a stren- 
uous effort to identify all cases of HD within the study area, and it was not 
so dependent on the records of institutionalized patients (Shokeir 1975). 
The preponderance of the evidence would seem to favor the notion that 
the HD gene increases the fertility of its carriers. One corollary of this con- 
clusion is that the prevalence of HD might be increasing. This is difficult to 
ascertain because of a lack of suitable historic data. Hayden (1981) does 
remark that in comparing older with more recent epidemiologic studies, a 
rise in prevalence is noted, but this could easily be secondary to more com- 
plete ascertainment of cases in recent studies. However, in their survey of 
HD in south Wales (UK), Harper et al. (1979) were able to estimate that 
the birth rate of HD carriers has remained constant throughout the twentieth 
century. During the same time interval, the birth rate of the general popu- 
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lation has dropped markedly, implying that the cohort-specific prevalence 
of HD may be increasing in their study population. 
For unknown reasons, this apparent increase in the fertility of HD vic- 
tims seems to be entirely due to heightened reproduction on the part of 
female HD victims. Men with HD seem to produce fewer offspring than 
normals and unaffected sibs. Female HD victims apparently also have a 
higher rate of bearing illegitimate children as compared with their unaffected 
sibs (Reed et al. 1958). Bird (1986) has speculated that the sex difference in 
fertility could be related to the excessive concentration of gonadotropin re- 
leasing hormone found in the hypothalami of female but not male HD 
victims. 
It seems likely that the HD gene increases fertility while subsequently 
causing early mortality. As such, it would appear to be the type of pleiotropic 
gene envisioned by Williams. This must, however, remain a hypothesis for 
two reasons. First, while reproductive output is a valuable index of biologic 
fitness, a better measure would be the number of progeny who survive to 
the age of reproductive maturity. Family disruption is a common feature of 
HD families (Oliver 1970), and this could adversely affect biologic fitness. 
Reed and Neel (1959) concluded that the children of HD victims suffer from 
an increased infant mortality rate and that relative biologic fitness would be 
reduced by a factor of 0.015. Second, while all studies comparing HD victim 
fertility with the general population have attempted to use age- and sex- 
matched controls, none has controlled for class or socioeconomic differ- 
ences. HD victims tend to come from lower socioeconomic strata (Reed et 
al. 1958; Mattson 1974), and this could confound the interpretation of fertility 
data. 
A study incorporating these demographic considerations should be pos- 
sible. One excellent candidate for such a study would be the well studied 
Venezuela cohort (Young et al. 1986). This remarkably large (hundreds of 
individuals) and geographically stable pedigree has been instrumental in ge- 
netic and natural history studies of HD. Molecular genetic analysis of this 
pedigree had allowed the ascertainment of the genetic carrier status of all 
individuals in this pedigree. Histocompatibility typing has also been done, 
which would allow the determination of paternity. It should be possible to 
determine the fertility and progeny survival rates of gene and nongene car- 
riers within this pedigree. Development of an appropriate demographic con- 
trol population would allow determination of the biologic fitness of the HD 
gene. 
Idiopathic Hemochromatosis 
Idiopathic Hemochromatosis (IH) is an autosomal recessive inherited dis- 
order of iron metabolism (Bothwell et al. 1983). IH is one of the most com- 
mon of human genetic diseases. Approximately 10% of the population of 
Europe and North America are heterozygous for the IH allele, and the prev- 
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alence of homozygotes is estimated at 0.3% of the population. Penetrance, 
however, is usually incomplete. The mean age of onset of symptoms is ap- 
proximately 50 with the vast majority of patients presenting between the 
ages of 40 and 60 (Finch and Finch 1955; Milder et al. 1980). IH is char- 
acterized by progressive deterioration in hepatic, endocrine pancreatic, car- 
diac, and pituitary function. Historically, untreated IH victims died within 
months after diagnosis. With the development of insulin therapy, the average 
period of survival was extended to four years, and the institution of thera- 
peutic phlebotomy has extended the average survival period to 16 years 
(Milder et al. 1980). The molecular basis of the underlying defect is unknown, 
but IH is characterized by excessive absorption and abnormal distribution 
of iron. The capacity of humans to excrete iron is quite limited, and iron 
stores are largely regulated by control of intestinal iron absorption. IH vic- 
tims have a dramatically heightened and unregulated capacity to absorb iron. 
They eventually saturate their normal iron storage capacity. Iron distribution 
then becomes abnormal, and progressive organ failure results. Even het- 
erozygotes have a mildly increased capacity to absorb iron, although this 
does not result in pathologic sequealae (Cartwright et al. 1979). 
The high prevalence of IH has lead to speculation that it may be the 
beneficiary of some positive selection pressure (Motulsky 1979; Rotter and 
Diamond 1987). The proposed advantage is that increased absorption of iron 
would help to combat the development of iron deficiency anemia. Such an 
advantage would be particularly marked for women during their reproductive 
years. Because of menstruation, pregnancy, and lactation, women tend to 
have smaller iron stores than men, and they are especially prone to develop 
iron deficiency anemia. An estimated 20% of women in the United States 
suffer from iron deficiency anemia, and this figure is much higher in de- 
veloping countries where diets are poor in iron and hookworm infection is 
prevalent (Lee et al. 1980). The greater demands placed on iron stores in 
women probably explains why female homozygotes suffer serious organ 
impairment at a rate 5-10 times less than male homozygotes and that average 
onset of symptoms in women occurs a few years after average onset in men 
(Finch and Finch 1955). It would appear that the probable benefits of the 
IH allele accrue mainly to women and that the late life complications are 
reduced as well. 
An alternative explanation for the high prevalence of the IH allele would 
be heterosis. Like sickle cell anemia, the benefit to heterozygotes could 
outweigh the morbidity and mortality imposed upon homozygotes. As men- 
tioned above, IH allele heterozygotes do have a mildly increased ability to 
absorb iron. This could provide them with a beneficial effect without in- 
curring the penalty of developing clinical hemochromatosis. However, under 
conditions in which increased iron absorption is advantageous, the homo- 
zygotes would continue to have an advantage over both heterozygotes and 
normals. This would be especially true for women. 
Evaluation of the biologic fitness of the IH allele could be carried out 
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in areas where iron deficiency anemia is common. One could compare in- 
dividuals, both heterozygotes and homozygotes for the IH allele, with 
matched controls and determine the prevalence of anemia within the two 
populations. One could also measure the reproductive success of IH allele 
hetero- and homozygotes to directly determine if this allele has a positive 
impact on biologic titness. The IH gene is closely linked to the histocom- 
patibility complex, and in Caucasian populations the IH allele is closely as- 
sociated with a particular HLA haplotype. IH allele carrier status could 
probably be assessed by iron studies or histocompatibility status or a com- 
bination of both. 
Pepsinogen 1 Related Peptic Ulcer Disease 
Peptic ulcer disease typically occurs in middle age. In one excellent popu- 
lation-based study, the median age of diagnosis was approximately 50, al- 
though the age specific incidence appears to rise linearly with age (Bonnevie 
1975). The average age of onset may have been earlier some decades past 
(Eusterman and Balfour 1936). It is relatively common with a lifetime prev- 
alence of at least 5% in Europe (Grossman 1980), and in Denmark the in- 
cidence appears to be 1.4 new cases per 1,000 per year (Bonnevie 1975). In 
addition to causing considerable pain and disability, it is often life threatening 
because of massive gastrointestinal hemorrhage. Even with the excellent 
medical and surgical therapy presently available, victims of peptic ulcer 
disease have a small but significant decrease in life expectancy (Bonnevie 
1978). This increased mortality seems to be especially pronounced among 
the elderly (Bonnevie 1978; Sonnenberg and Fritsch 1983). Several decades 
ago, the mortality rate was much higher with a nine-year cumulative mor- 
tality rate of 15% (Moutier 1932). Prior to the development of successful 
surgical techniques in the late nineteenth century, the mortality rate would 
have been much higher. 
Several lines of evidence indicate that there is a substantial genetic 
component in susceptibility to peptic ulcer disease (Peterson and Rotter 
1983). One well characterized genetic syndrome that predisposes to peptic 
ulcers is the overproduction of pepsinogen 1 (PGl) (Rotter et al. 1979a; 
Rotter et al. 1979b). This protein is a precursor to the proteolytic enzyme 
pepsin and is secreted into the stomach in the course of digestion. Excessive 
production of PGI is inherited in an autosomal dominant manner. Hyperse- 
cretors of PGl can also be identified by an elevated concentration of PGl 
in serum. In some series, hypersecretion of PGI is present in 50% of peptic 
ulcer disease patients (Samloff et al. 1975a; Rotter et al. 1979b), although 
not all individuals with elevated PGI develop ulcers. The hypersecretion of 
PGl is accompanied by excessive production of acid by the gastric mucosa 
(Samloff et al. 1975b; Rotter et al. 1979b). 
Rotter and his colleagues (Rotter and Diamond 1987; Peterson and Rot- 
ter 1983) have speculated that gastric hyperacidity may confer some selective 
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advantage because gastric acidity appears to form a nonspecific barrier to 
infection. This is especially important in the case of enteric infections and 
also may be a factor in resistance to tuberculosis. Decreased gastric acid 
secretion predisposes to cholera infection (Nalin et al. 1978). Individuals 
who have undergone partial gastric resection generally have reduced acid 
secretion and an increased susceptibility to tuberculosis (Balint 1958). Rotter 
et al. have pointed out that the putative benefits of gastric acid hypersecre- 
tion would have been especially marked in nineteenth-century Europe when 
tuberculosis was a leading cause of death and morbidity. These authors have 
further speculated that the selective pressure exerted by tuberculosis could 
have accounted for the marked rise in prevalence of peptic ulcer seen in the 
first half of the twentieth century (Ivey 1950). 
This hypothesis could be tested in an area where tuberculosis and/or 
cholera are still prevalent. PGl hypersecretors could be identified by mea- 
surement of serum PGl levels, and the incidence rate of tuberculosis and/ 
or cholera in hypersecretors and normals could be compared. 
CONCLUSIONS 
This article has explored the possibility that study of human aging and human 
genetic diseases may allow verification of the pleiotropic gene theory of 
senescence. Predictions derived from the pleiotropic gene theory do accord 
with some of the known facts about human aging. In addition, certain human 
adult onset genetic diseases may exemplify the type of phenotypic effects 
predicted by the pleiotropic gene theory. While none of these genes can be 
definitively identified as a pleiotropic senescence gene, the available evi- 
dence is suggestive. All of these alleles may increase biologic fitness early 
in adult life and certainly cause increased mortality and morbidity later in 
life. Also in keeping with the pleiotropic gene .theory is the fact that these 
candidate alleles occupy distinct loci and exert their deleterious effects on 
different organs and through different pathophysiologic mechanisms. 
As discussed above, it should be possible to evaluate the biologic fitness 
of each of these alleles. Ultimately, one would wish to exclude the possibility 
of a transient polymorphism by following a study population for many gen- 
erations to determine if there is an increasing frequency of the candidate 
allele within that population. However, in the absence of good historic in- 
formation, it would be impossible to conduct such a longitudinal study in 
humans. This is especially true for industrialized countries because modern 
medicine has altered the natural history of diseases like IH and peptic ulcer 
disease. Consequently, the approach outlined above is probably the optimal 
one for the identification and evaluation of candidate human senescence 
genes. Several other adult onset human genetic diseases could also be eval- 
uated as candidate pleiotropic senescence genes. This could include such 
common disorders as familial Alzheimer’s disease, atherosclerotic heart dis- 
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ease, and adult onset diabetes mellitus. Indeed, it has already been suggested 
that the alleles for adult onset diabetes mellitus have may conferred a se- 
lective advantage in preindustrial societies by optimizing carbohydrate me- 
tabolism under starvation conditions (Neel 1982). 
The identification of even one gene or allele as a pleiotropic senescence 
gene would be strong evidence in favor of this theory of senescence. The 
consequences for gerontologic research and care of the elderly could be 
profound. The pleiotropic gene theory predicts that life span is genetically 
limited and that senescence is the probable product of multiple genes. Con- 
sequently, present efforts to define a single proximate mechanism of se- 
nescence and to manipulate that mechanism in the hope of extending life 
span would be doomed to failure and thus represent a waste of resources. 
Likewise, if aging and ultimately mortality are the result of a multiplicity of 
genetic effects, heroic efforts to prolong the lives of the elderly will be ul- 
timately fruitless. 
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